Latest Generalised epilepsy Stories
-- Primary efficacy and safety data from the largest Phase 3 brivaracetam study involving 768 patients presented at the 68th Annual Meeting of the American Epilepsy Society BRUSSELS, Dec.
Nationwide, fundraising and charity events are held in hopes to raise awareness and funds to further research treatments and better understand the diseases in order to create a better future for
Eisai Submits Applications for Antiepilepsy Agent Fycompa Simultaneously In Europe and U.S.
- Brivaracetam is the newest investigational medicine to emerge from UCB's rich late-stage pipeline BRUSSELS, July 23, 2014 /PRNewswire/ -- regulated information -- UCB today announced an important
Transparency Market Research added a new report "Global Epilepsy Therapeutics Market: Industry Analysis, Size, Share, Growth and Forecast 2019" to its report store.
New research reveals a shared genetic susceptibility to epilepsy and migraine.
Epilepsy specialists will share their most updated knowledge on how to treat epilepsy and seizures through diets, epilepsy surgery, and anti-epileptic medications.
- To swell, as grain or wood with water.